Moores Cancer Center’s Paula Aristizabal, MD, MAS, coauthored the inaugural AACR Pediatric Cancer Progress Report 2025. As the only UC representative, she highlights advances like 30+ new pediatric cancer drugs and ongoing challenges, including disparities in outcomes and the ne
Leaders in oncology research, technology, and patient advocacy gathered in San Diego for the Innovations in Oncology Clinical Trial Design symposium, presented by UC San Diego Moores Cancer Center in partnership with Biocom California. The half-day program focused on new models of clinical trials
Diane M. Simeone, MD, director of Moores Cancer Center at UC San Diego Health, has been elected to the Board of Directors of the Association of American Cancer Institutes (AACI).
UC San Diego has once again been recognized among the top institutions in the world on the 2025 Highly Cited Researchers list compiled by Clarivate. UC San Diego tied for 18th in the world this year with UCLA. Both schools have 50 recognitions on the Highly Cited Researchers listing.
UC San Diego researchers have developed a new targeted therapy for triple-negative breast cancer, the most difficult-to-treat subtype of the disease.
The University of California San Diego has announced that Amir Zarrinpar, M.D., Ph.D., has been appointed as the inaugural holder of the Stuart and Barbara L. Brody Endowed Chair in Circadian Biology and Medicine.
The Hill, November 14
Keep up with all the latest from Moores Cancer Center. Subscribe to the newsletter today.
